Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood. - Test2 - elhamkhani - TriplyDB

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

http://www.wikidata.org/entity/Q37273675

about

Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.DNA methylation in repetitive elements and Alzheimer disease Clinical chemistry: challenges for analytical chemistry and the nanosciences from medicine.Current therapies and new strategies for the management of Alzheimer's disease.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.

P2860

Q28396741-D65E735C-30CC-4E93-8A22-15811D28034F Q30871982-04D2A628-5412-4503-A465-F649766FBF61 Q35029099-8E7FF182-3B9E-42FB-98B9-81909DCCDC7F Q35034130-370D2804-CE94-4456-A791-1A85AAE2809A Q37091491-2C7EC838-1A4E-443D-B021-56626FDF3648 Q37664696-6F6BB7CA-9988-42EE-A165-D9980FA89910 Q37770005-4E72D3E6-774D-4722-B339-F40D036515BE Q47407570-FAA31312-1329-48FD-8710-09214B344A2B

P2860

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

http://www.wikidata.org/entity/Q37273675

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

@en

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

@nl

type

label

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

@en

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

@nl

prefLabel

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

@en

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

@nl

P1433

Q37273675-3A23A8D2-FC55-4FBC-A86B-5CB509F0B555

P1476

Q37273675-C4BCC750-3E17-492E-94A7-CDFC79EA0BCB

P2093

Q37273675-77E250F3-05DC-4416-804D-16DEABBE5226

P2860

Q37273675-00FA3C19-9B28-4D62-8017-AAD7CEDB4895

Q37273675-05381724-061E-4D64-A715-23DB29E1DDA0

Q37273675-059A5CC2-54B0-4816-ABE0-8F6B341B0FF8

Q37273675-0673301E-28DC-42E8-BD48-8507ABD5ACE7

Q37273675-075D3F2A-9128-4179-B39C-741500226A05

Q37273675-08B9D029-B2A5-4212-962C-A53BB517A66A

Q37273675-08F20366-8970-42E4-A150-24CADE9ED867

Q37273675-09625C80-DFDB-406C-9FD5-871FACA97652

Q37273675-0A530C72-C064-4E5E-978F-7C87C25C3FBB

Q37273675-0B881293-5692-4481-AFD9-5DF585FB4A81

P2888

Q37273675-CEE667EA-5411-490C-9161-CF656CF62C5A

P304

Q37273675-C2AC6A6B-95A9-4750-A308-9BE256F6B67F

P31

Q37273675-816E6D89-E013-4482-B921-49D1672ACBBC

Q37273675-fb886331-a24b-428e-ad61-a4fa76b0e20f

P356

Q37273675-458714C1-FA23-4F11-8AD1-78DED0195DCF

P433

Q37273675-48C23C25-91D2-4E0E-B7D3-A4DD44554CC2

P478

Q37273675-4B63EDB0-448C-4963-AF7B-185586B750C9

P577

Q37273675-F31C72DE-031B-436A-B66B-753871C83CA7

P698

Q37273675-353EFC9C-44B5-4A13-8924-A4123B63A6EE

P921

Q37273675-8BA29809-570A-421E-8BB4-81F46D6B28ED

Q37273675-AA5D8439-9CA3-4D6D-8947-67824BED93C7

Q37273675-DE83E625-83C8-4C91-8718-955F8AA4D881

P356

P1433

Molecular Diagnosis and Therapy

P1476

Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

@en

P2093

Anders Lönneborg

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer Disease in the US Population

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

The role of biomarkers in clinical trials for Alzheimer disease

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.

Disease-modifying therapies for Alzheimer disease: challenges to early intervention.

P2888

P304

307-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03256296

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18803429

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid